Binigyan na ng emergency use authorization (EUA) ng Food and Drug Administration (FDA), Huwebes, 23 Dec., ang anti-COVID-19 drug Molnupiravir.
Sa anunsyo ni FDA Director General Eric Domingo sa Laging Handa briefing na gagamitin ang Molnupiravir para sa mga pasyenteng may mild hanggang moderate na COVID-19 symptoms.
“This can only be given to adults aged 18 and above, who tested positive for COVID-19 and are at risk of developing severe illness,” ani Domingo.
“Molnupiravir is given twice a day for five days, but should be given as soon as possible after diagnosis. And it should be given within the first five days after the onset of symptoms,” dagdag pa niya.
Sa pamamagitan ng EUA maaari nang gamitin sa bansa ang isang gamot pero hindi pa rin ito maaaring ibenta.
(Toni Tambong)
The post Anti-COVID drug Molnupiravir, binigyan na ng emergency use authorization ng FDA appeared first on News Patrol.
Anti-COVID drug Molnupiravir, binigyan na ng emergency use authorization ng FDA
Source: Trending Filipino News
0 Comments